Transdermal scopolamine for motion sickness.
D002986:Clinical Trials as Topic; D006801:Humans; D009041:Motion Sickness / Q000188:drug therapy*; D012601:Scopolamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D012869:Skin Absorption
D012601:Scopolamine